We are live on ! Find out more
CCM

Cadian Capital Management Portfolio holdings

AUM $1.32B
1-Year Est. Return 4.19%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+4.19%
3 Year Est. Return
+19.53%
5 Year Est. Return
+29.99%
10 Year Est. Return
+331.01%
AUM
$1.9B
AUM Growth
+$75.3M
Cap. Flow
-$91.8M
Cap. Flow %
-4.84%
Top 10 Hldgs %
55.98%
Holding
58
New
14
Increased
16
Reduced
16
Closed
7

Sector Composition

Rank Sector Weight
1 Communication Services 25.34%
2 Healthcare 24.05%
3 Technology 23.01%
4 Consumer Discretionary 10.8%
5 Financials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSIC icon
26
Henry Schein
HSIC
$9.73B
$24.4M 1.29%
+382,500
New +$25.4M
BABA icon
27
Alibaba
BABA
$270B
$21.9M 1.16%
+207,000
New +$19.2M
VISN
28
Vistance Networks Inc
VISN
$1.48B
$19.1M 1.01%
+635,000
New +$19.2M
UHS icon
29
Universal Health Services
UHS
$10.2B
$19.1M 1.01%
+155,000
New +$19.6M
CHTR icon
30
Charter Communications
CHTR
$16.7B
$16.7M 0.88%
61,743
-362,500
-85% -$91.6M
PANW icon
31
Palo Alto Networks
PANW
$275B
$14.3M 0.76%
+540,000
New +$12.3M
LVNTA
32
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$14M 0.74%
350,000
KTWO
33
DELISTED
K2M Group Holdings, Inc
KTWO
$13.4M 0.71%
754,252
+204,311
+37% +$3.43M
MSFT icon
34
Microsoft
MSFT
$3.64T
$13.2M 0.7%
230,000
+10,000
+5% +$564K
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
$13M 0.69%
529,458
-400,000
-43% -$9.21M
GOOGL icon
36
Alphabet (Google) Class A
GOOGL
$4.07T
$10.5M 0.55%
260,000
FTR
37
PUT
DELISTED
Frontier Communications Corp.
FTR
$10.4M 0.55%
+166,667
New +$11.9M
COLL icon
38
Collegium Pharmaceutical
COLL
$744M
$9.25M 0.49%
+480,141
New +$5.7M
LOGM
39
DELISTED
LogMein, Inc.
LOGM
$8.5M 0.45%
93,991
-393,391
-81% -$31.5M
ALDR
40
DELISTED
Alder Biopharmaceuticals
ALDR
$7.89M 0.42%
240,665
-376,200
-61% -$11.5M
CYH icon
41
Community Health Systems
CYH
$406M
$4.62M 0.24%
+400,000
New +$4.61M
REGN icon
42
Regeneron Pharmaceuticals
REGN
$82.1B
$4.02M 0.21%
10,000
-10,000
-50% -$4.01M
ARIA
43
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$3.42M 0.18%
250,000
-250,000
-50% -$2.51M
DBVT
44
DBV Technologies
DBVT
$816M
$3.39M 0.18%
9,319
VRNT
45
DELISTED
Verint Systems
VRNT
$2.83M 0.15%
147,370
+86,117
+141% +$1.55M
ZGNX
46
DELISTED
Zogenix, Inc.
ZGNX
$2.2M 0.12%
192,500
+45,000
+31% +$415K
XBIT icon
47
XBiotech
XBIT
$65.9M
$1.88M 0.1%
+139,829
New +$2.05M
NBIX icon
48
Neurocrine Biosciences
NBIX
$15.9B
$1.62M 0.09%
31,956
-272,926
-90% -$13.6M
IRWD icon
49
Ironwood Pharmaceuticals
IRWD
$658M
$1.59M 0.08%
+119,400
New +$1.4M
MTCH icon
50
Match Group
MTCH
$9.62B
$1.46M 0.08%
+82,066
New +$1.31M

Similar funds

Cadian Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Cadian Capital Management held 58 positions worth $1.9B, up 4.1% from $1.82B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cadian Capital Management withdrew a net $91.8M in Q3 2016, closing 7 positions and reducing 16 holdings. Its most notable exit was TriNet, an estimated $44.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cadian Capital Management opened a new position in Celgene Corp worth $39.7M.

  • Cadian Capital Management's largest Q3 2016 buy was Celgene Corp: 380,000 shares worth $39.7M.
  • Cadian Capital Management added most to Jazz Pharmaceuticals in Q3 2016, an estimated $73.7M increase.
  • Cadian Capital Management's biggest Q3 2016 reduction was Charter Communications, cutting an estimated $91.6M.
  • Cadian Capital Management fully exited TriNet in Q3 2016, selling an estimated $44.3M.
  • Cadian Capital Management's ten largest holdings make up 56% of its $1.9B portfolio in Q3 2016.
  • Cadian Capital Management opened 14 new positions and closed 7 in Q3 2016.
  • Cadian Capital Management's portfolio value rose 4.1% quarter-over-quarter to $1.9B.

Based on Cadian Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.